Tirzepatide is the active ingredient that acts as a dual agonist of GLP-1 and GIP receptors and has been shown to help people lose significant amounts of body weight, with some studies reporting up to 22.5%* reduction in body weight
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Latest Study Finds A Strong Link health-news ChatGPT Health Becomes Available For Eligible Users In US: Pros & Cons Of Letting AI Access Your Medical Records health-news Scientists Say Changes In Brain In Your 40s & 50s May Influence Dementia Risk Home Nutrition These Foods Can Mimic The Effects Of Ozempic
That may be good news for GLP-1 users, but important questions remain
Neuroprotection and Nerve Repair : BPC-157 supports neuronal survival and nerve regeneration by modulating dopamine, serotonin, and GABA pathways
Patients in Canada, the UK, and many European countries pay far less for the same medication